全球腫瘤資訊系統市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計腫瘤資訊系統市場將從 2025 年的 33.5 億美元成長到 2034 年的 70.3 億美元，2026 年至 2034 年的複合年成長率為 8.61%。

由於全球癌症發生率不斷上升以及對高效能患者數據管理的需求日益成長，全球腫瘤資訊系統市場正經歷顯著成長。這些系統有助於簡化腫瘤診療流程、管理病患病歷並改善治療方案。醫療保健領域數位化技術的整合正在加速其應用，尤其是在旨在改善臨床療效和營運效率的醫院和癌症治療中心。

推動成長的因素包括醫療資訊IT基礎設施的進步以及對個人化癌症治療日益成長的關注。腫瘤資訊系統能夠實現醫療專業人員之間的無縫數據共用，從而改善協作和決策。此外，電子健康記錄 (EHR) 的日益普及和雲端解決方案的採用也促進了市場擴張。各國政府推動數位化醫療轉型的措施也進一步提升了全球對這些系統的需求。

隨著人工智慧 (AI) 和數據分析技術與腫瘤治療系統的整合日益加深，市場前景仍然強勁。這些技術將提升預測分析能力和治療精準度。儘管北美目前佔據市場主導地位，但由於醫療保健的現代化進程，亞太地區預計將迎來快速成長。雖然高昂的實施成本和資料安全問題等挑戰依然存在，但持續的技術進步將繼續推動市場發展。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球腫瘤資訊系統市場：依產品及服務分類

• 市場分析、洞察與預測
• 解決方案（病患資訊系統、治療計畫系統、專業服務）

第5章 全球腫瘤資訊系統市場：依應用領域分類

• 市場分析、洞察與預測
• 腫瘤內科
• 放射腫瘤學
• 外科腫瘤學

第6章 全球腫瘤資訊系統市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診斷影像中心
• 消融治療中心和癌症治療中心
• 政府機構
• 研究設施

第7章 全球腫瘤資訊系統市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Accuray Incorporated
  • Elekta AB
  • Brainlab AG
  • DOSIsoft SA
  • Flatiron Health
  • RaySearch Laboratories AB
  • Oracle Corporation（Cerner）
  • Koninklijke Philips NV
  • Varian Medical Systems Inc
  • Siemens Healthineers

The Oncology Information System Market size is expected to reach USD 7.03 Billion in 2034 from USD 3.35 Billion (2025) growing at a CAGR of 8.61% during 2026-2034.

The Global Oncology Information System Market is witnessing significant growth due to the rising prevalence of cancer worldwide and the increasing need for efficient patient data management. These systems help streamline oncology workflows, manage patient records, and improve treatment planning. The integration of digital technologies in healthcare is accelerating adoption, particularly in hospitals and cancer treatment centers aiming to enhance clinical outcomes and operational efficiency.

Growth drivers include advancements in healthcare IT infrastructure and the growing emphasis on personalized cancer treatment. Oncology information systems enable seamless data sharing among healthcare providers, improving coordination and decision-making. Additionally, the increasing use of electronic health records (EHRs) and the adoption of cloud-based solutions are supporting market expansion. Government initiatives promoting digital healthcare transformation are further fueling demand for these systems globally.

Future prospects remain strong as artificial intelligence and data analytics become more integrated into oncology systems. These technologies will enhance predictive analysis and treatment accuracy. North America currently dominates the market, but Asia-Pacific is expected to grow rapidly due to healthcare modernization. Challenges such as high implementation costs and data security concerns persist, but ongoing technological advancements will continue to drive market evolution.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Products & Services

• Solutions (Patient Information Systems, Treatment Planning Systems, Professional Services)

By Application

• Medical Oncology
• Radiation Oncology
• Surgical Oncology

By End-use

• Hospitals and Diagnostic Imaging Centers
• Ablation Care Centers and Cancer Care Centers
• Government Institutions
• Research Facilities

COMPANIES PROFILED

• Accuray Incorporated, Elekta AB, Brainlab AG, DOSIsoft SA, Flatiron Health, RaySearch Laboratories AB, Oracle Corporation Cerner, Koninklijke Philips NV, Varian Medical Systems Inc, Siemens Healthineers
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET: BY PRODUCTS & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Products & Services
• 4.2. Solutions (Patient Information Systems, Treatment Planning Systems, Professional Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Medical Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Radiation Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Surgical Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals and Diagnostic Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ablation Care Centers and Cancer Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Government Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Research Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Products & Services
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Products & Services
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Products & Services
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Products & Services
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Products & Services
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ONCOLOGY INFORMATION SYSTEM INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Accuray Incorporated
  • 9.2.2 Elekta AB
  • 9.2.3 Brainlab AG
  • 9.2.4 DOSIsoft SA
  • 9.2.5 Flatiron Health
  • 9.2.6 RaySearch Laboratories AB
  • 9.2.7 Oracle Corporation (Cerner)
  • 9.2.8 Koninklijke Philips N.V
  • 9.2.9 Varian Medical Systems Inc
  • 9.2.10 Siemens Healthineers